Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015:2015:437298.
doi: 10.1155/2015/437298. Epub 2015 Jan 22.

Liver Transplant in a Patient under Methylphenidate Therapy: A Case Report and Review of the Literature

Affiliations

Liver Transplant in a Patient under Methylphenidate Therapy: A Case Report and Review of the Literature

Hoi Y Tong et al. Case Rep Pediatr. 2015.

Abstract

Background. Methylphenidate (MPH) is widely used in treating children with attention-deficit-hyperactivity disorder. Hepatotoxicity is a rare phenomenon; only few cases are described with no liver failure. Case. We report on the case of a 12-year-old boy who received MPH for attention-deficit-hyperactivity disorder. Two months later the patient presented with signs and symptoms of hepatitis and MPH was discontinued, showing progressive worsening and developing liver failure and a liver transplantation was required. Other causes of liver failure were ruled out and the liver biopsy was suggestive of drug toxicity. Discussion. One rare adverse reaction of MPH is hepatotoxicity. The review of the literature shows few cases of liver injury attributed to MPH; all of them recovered after withdrawing the treatment. The probable mechanism of liver injury was MPH direct toxicity to hepatocytes. In order to establish the diagnosis of MPH-induced liver injury, we used CIOMS/RUCAM scale that led to an assessment of "possible" relationship. This report provides the first published case of acute MPH-induced liver failure with successful hepatic transplantation. Conclusions. It is important to know that hepatotoxicity can occur in patients with MPH treatment and monitoring the liver's function is highly recommended.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Liver biopsy.

Similar articles

Cited by

References

    1. Greenhill L., Kollins S., Abikoff H., et al. Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry. 2006;45(11):1284–1293. doi: 10.1097/01.chi.0000235077.32661.61. - DOI - PubMed
    1. Greenhill L. L. Stimulant medication treatment of children with attention deficit hyperactivity disorder. In: Jensen P. S., Cooper J. R., editors. Attention Deficit Hyperactivity Disorder: State of Science. Best Practices. Kingston, NJ, USA: Civic Research Institute; 2002. pp. 9–27.
    1. Subcommittee on Attention-Deficit/Hyperactivity Disorder. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/ hyperactivity disorder in children and adolescents. Pediatrics. 2011;128(5):1007–1022. doi: 10.1542/peds.2011-2654. - DOI - PMC - PubMed
    1. Arcieri R., Germinario E. A. P., Bonati M., et al. Cardiovascular measures in children and adolescents with attention-deficit/hyperactivity disorder who are new users of methylphenidate and atomoxetine. Journal of Child and Adolescent Psychopharmacology. 2012;22(6):423–431. doi: 10.1089/cap.2012.0014. - DOI - PubMed
    1. Martinez-Raga J., Knecht C., Szerman N., Martinez M. I. Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder. CNS Drugs. 2013;27(1):15–30. doi: 10.1007/s40263-012-0019-9. - DOI - PubMed

LinkOut - more resources